Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Stockholders Equity of $206.75 million for fiscal year 2025.
ASSEMBLY BIOSCIENCES, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $206.75M | +519.8% |
| 2024 | $33.36M | -18.8% |
| 2023 | $41.10M | -50.3% |
| 2022 | $82.66M | -51.1% |
| 2021 | $168.93M | -29.8% |
| 2020 | $240.58M | -11.9% |
| 2019 | $273.22M | +29.7% |
| 2018 | $210.65M | +86.2% |
| 2017 | $113.12M | +41.6% |
| 2016 | $79.88M | -32.7% |
| 2015 | $118.74M | +102.7% |
| 2014 | $58.57M | +139.1% |
| 2013 | $24.49M | +37.5% |
| 2012 | $17.81M | -48.4% |
| 2011 | $34.53M | +197.0% |
| 2010 | $11.63M | +187.0% |
| 2009 | -$13.36M | -41.3% |
| 2008 | -$9.46M | -115.8% |
| 2007 | -$4.38M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $182.69M | +602.6% | +909.4% |
| June 30, 2025 | $18.10M | -47.8% | -33.3% |
| March 31, 2025 | $27.13M | -16.8% | -18.7% |
| December 31, 2024 | $33.36M | -18.8% | +28.3% |
| September 30, 2024 | $26.00M | -37.7% | -25.0% |
| June 30, 2024 | $34.68M | -36.9% | +6.4% |
| March 31, 2024 | $32.60M | -53.6% | -20.7% |
| December 31, 2023 | $41.10M | -50.3% | -1.5% |
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +519.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, ASSEMBLY BIOSCIENCES, INC.’s stockholders equity has grown by 4818.1% (from -$4.38 million to $206.75 million).
- The most recent figure is from ASSEMBLY BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: